Regenerative Medical Technology Group Inc. (RMTG) stock: key figures, P/E, revenue and dividend

Consumer Discretionary · United States

Price
0.03 USD
Market cap
412,169.04 USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Regenerative Medical Technology Group Inc. financials

Fiscal year2025
Revenue5.10 m USD
Gross profit2.81 m USD
Operating income-867,162.00 USD
EBIT-2.01 m USD
Net income-7.81 m USD
Diluted EPS – continuing operations-0.62 USD

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. Further, it provides solutions from clinical research with the manufacturing and commercialization of viable cell therapy and immune support related products. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.